Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.

Tschautscher, Marcella A; Jevremovic, Dragan; Rajkumar, Vincent; Dispenzieri, Angela; Lacy, Martha Q; Gertz, Morie A; Buadi, Francis K; Dingli, David; Hwa, Yi L; Fonder, Amie L; Hobbs, Miriam A; Hayman, Suzanne R; Zeldenrust, Steven R; Lust, John A; Russell, Stephen J; Leung, Nelson; Kapoor, Prashant; Go, Ronald S; Lin, Yi; Gonsalves, Wilson I; Kourelis, Taxiarchis; Warsame, Rahma; Kyle, Robert A; Kumar, Shaji K.
Am J Hematol; 94(7): 751-756, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30945330

Não foram localizados documentos relacionados